Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2007
12/06/2007CA2653371A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
12/06/2007CA2653319A1 Hsp90 inhibitor
12/06/2007CA2653072A1 Method for elevating prolactin in mammals
12/06/2007CA2652164A1 Compounds for the treatment of alzheimer's disease
12/06/2007CA2652044A1 Pyrrolopyrimidine compounds and their uses
12/06/2007CA2651857A1 Aryl-4-ethynyl-isoxazole derivatives
12/06/2007CA2651849A1 Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
12/06/2007CA2650622A1 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
12/06/2007CA2650147A1 Benzazepine derivatives as monoamine reuptake inhibitors
12/05/2007EP1862475A1 Polymer conjugates of neublastin and methods of using same
12/05/2007EP1862458A2 Therapeutic agents useful for treating pain
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases
12/05/2007EP1862450A2 Novel compounds
12/05/2007EP1862444A2 Ether compounds, compositions, and uses thereof
12/05/2007EP1862171A1 A medicine composition for treating muscular atrophy and myasthenia gravis and method of preparing the same
12/05/2007EP1862158A1 A pharmaceutical composition for treating depression and method for preparation thereof
12/05/2007EP1861406A2 Hydrocodone polymorphs
12/05/2007EP1861399A2 Cgrp receptor antagonists
12/05/2007EP1861394A1 Substituted pyridine derivatives
12/05/2007EP1861392A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/05/2007EP1861390A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/05/2007EP1861380A1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
12/05/2007EP1861375A1 Dipyrazoles as central nervous system agents
12/05/2007EP1861363A1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors
12/05/2007EP1861360A1 Pyrrolidine derivatives as histamine h3 receptor antagonists
12/05/2007EP1861107A2 Treatment of amyotrophic lateral sclerosis with norethindrone and analogues
12/05/2007EP1861105A1 Process for the preparation of galanthamine hydrobromide
12/05/2007EP1861103A1 Composition comprising ocaperidone
12/05/2007EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1585510B1 Alpha-aminoamide derivatives useful as antimigraine agents
12/05/2007EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
12/05/2007EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/05/2007EP1173252B1 Products for brachytherapy and methods for their production
12/05/2007EP1170006B1 Drug for alleviating migrane
12/05/2007CN101084227A Rapamycin analogues and the uses thereof in the treatment of neurological disorders
12/05/2007CN101084225A Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity
12/05/2007CN101084223A Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors
12/05/2007CN101084222A Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
12/05/2007CN101084220A Halogen substituted benzodiazepine derivatives
12/05/2007CN101084219A Pyrazolo(1,5-alpha)pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists
12/05/2007CN101084215A Piperidine and azetidine derivatives as GLYT1 inhibitors
12/05/2007CN101084204A Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
12/05/2007CN101084201A Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
12/05/2007CN101084199A Substituted amino-compounds and uses thereof
12/05/2007CN101084198A Substituted amino-pyrimidones and uses thereof
12/05/2007CN101084193A Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
12/05/2007CN101084009A Gh secretagogues and uses thereof
12/05/2007CN101083984A Therapeutic compositions for intranasal administration of ketorolac
12/05/2007CN101081869A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081868A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081867A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081850A 7-phenylpyrazolopyridine compounds
12/05/2007CN101081817A Novel O-demethylated-venlafaxine maleate
12/05/2007CN101081816A Novel O-demethylated-venlafaxine tartrate
12/05/2007CN101081815A Novel O-demethylated-venlafaxine citrate
12/05/2007CN101081278A Chinese medicinal materials preparations for treating depression
12/05/2007CN101081273A Chinese medicinal materials for treating dizziness
12/05/2007CN101081272A Medicine for treating dumps emotional handicap type disease
12/05/2007CN101081259A Chinese medicinal materials decoction for treating top-left fenghuo tooth pain
12/05/2007CN101081218A Rapid-disintegrated oral film and method for making same
12/05/2007CN101081217A Slow-release small pill prparation containing huperzine A and method for making same
12/05/2007CN101081215A Conotoxin SO3 nanometer grain composition and method of making the same and the application thereof
12/05/2007CN101081091A Vision-improving and intelligent-improving beverage
12/05/2007CN101081075A Selenium germanium peptide jujube tea paste for effecting radical cure of tuberculosis, slow and fume
12/05/2007CN101081049A Green grape health tea
12/05/2007CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007CN100352921C Compositions and methods for identifying antigens which elicit an immune response
12/05/2007CN100352842C Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
12/05/2007CN100352817C Pyridinoylpiperidines as 5-HTLF agonists
12/05/2007CN100352816C Nociceptin analogs
12/05/2007CN100352807C Chemical compounds
12/05/2007CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/05/2007CN100352804C 酰胺衍生物 Amide derivatives
12/05/2007CN100352509C Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
12/05/2007CN100352506C Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
12/05/2007CN100352459C Method for utilizing fermentative soybean liquid extract
12/05/2007CN100352457C Apocynum extract and extracting method thereof
12/05/2007CN100352450C Albumen removed extraction of calf blood for injection and its preparing process
12/05/2007CN100352447C Anxiolytic matter extracted from preparata
12/05/2007CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/05/2007CN100352440C Orally dispersible pharmaceutical piribedil composition
12/05/2007CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
12/05/2007CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation
12/05/2007CN100352431C Pharmaceutical salts
12/04/2007US7304158 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide
12/04/2007US7304129 Peptides that stimulate cell survival and axon regeneration
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction
12/04/2007US7304076 Dietetics; antidiabetic agents; eating disorders
12/04/2007US7304072 Spiro compounds
12/04/2007US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007US7304070 eg 8-(4-{[3-(2-methylphenyl)(1,2,4-oxadiazol-5-yl)]methoxy}phenyl)-1,3-dipropyl-1,3,7-trihydropurine-2,6-dione; atherosclerosis, angiogenesis, diabetic retinopathy, cancer, asthma, diarrhea, senile dementia, Alzheimer's disease, or Parkinson's disease
12/04/2007US7304069 Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
1 ... 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 ... 1833